About this trial
This registry prospectively collects anonymized free-text symptom descriptions submitted voluntarily by adults through the OpenGenome platform at opengenome.bio. For each submission, the system retrieves real biomedical literature from PubMed and ClinicalTrials.gov in parallel, applies a constrained reasoning model operating under a strict output schema, and returns a structured biological signal report. The study evaluates the internal consistency of extracted signals, the calibration of confidence scores relative to dataset size and symptom specificity, and the distribution of biological signal categories across a large anonymous population. No intervention is assigned. No participant contact occurs. All data is anonymized at the point of collection.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Automated or programmatically generated submissions detected by rate limiting
Submissions containing no discernible symptom or health-related content
Disqualifiers
None
Trial population
Adults aged 18 years or older who voluntarily access the OpenGenome platform at opengenome.bio and submit a free-text description of symptoms or health-related observations for automated biomedical signal analysis.
Trial design
Ecologic or community
Prospective
Treatments tested in this trial
OpenGenome AI Platform
Other interventionAI-assisted biomedical signal extraction from free-text symptom descriptions, cross-referenced against PubMed and ClinicalTrials.gov evidence sources.
Treatment groups
Trial outcomes
Primary outcomes
Internal signal-source concordance rate
Proportion of primary signal claims in generated reports that are traceable to at least one retrieved PubMed or ClinicalTrials.gov source included in the same report